CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Open-market sale Director sold 4,000 shares at $7.98 ($31,920)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Open-market sale Director sold 12,866 shares at $8.04 ($103,443)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 4 Grant or award Director acquired 16,745 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 680 shares (grant or award)
- 4 Grant or award Director acquired 1,360 shares (grant or award)
- 4 Grant or award Director acquired 680 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 4 Planned sale Chief R&D Officer sold 7,000 shares at $8.29 ($58,030)
- 4 Option exercise President & CEO acquired 31,055 shares (option exercise)
Page 14 of 99 · 1,967 filings